Screening for hemochromatosis: a cost-effectiveness study based on 12,258 patients.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Gastroenterology

• Publication date

  1994-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0016-5085(94)90171-6PMID 8039622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence of iron overload in central Sweden.

  2009cited by this paper
• Screening for iron overload using transferrin saturation.

  2009cited by this paper
• Long-term survival analysis in hereditary hemochromatosis.

  1991cited by this paper
• Clinical presentation of hemochromatosis: a changing scene.

  1991cited by this paper
• Comparison of stainable liver iron between symptomatic and asymptomatic hemochromatosis homozygotes and their homozygous relatives.

  1991cited by this paper
• Screening for haemochromatosis: prevalence among Danish blood donors

  1991cited by this paper
• Southern blood club symposium: an update on selected aspects of hemochromatosis.

  1990cited by this paper
• Phenotypic expression of the HLA linked iron‐loading gene in males over the age of 40 years: a population study using serial serum ferritin estimations

  1990cited by this paper
• Screening for hemochromatosis.

  1988cited by this paper
• Prevalence of hemochromatosis among 11,065 presumably healthy blood donors.

  1988cited by this paper
• Prevalence of hemochromatosis in a random sample of asymptomatic men.

  1986cited by this paper
• Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.

  1985cited by this paper
• Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.

  1984cited by this paper
• Diagnosis of hemochromatosis in young subjects: Predictive accuracy of biochemical screening tests

  1984cited by this paper
• Diagnostic efficacy of screening tests for hereditary hemochromatosis.

  1984cited by this paper
• Genetic and phenotypic expression of hemochromatosis in Canadians.

  1983cited by this paper
• Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees.

  1982cited by this paper
• Homozygosity for hemochromatosis: clinical manifestations.

  1980cited by this paper
• Serum-ferritin in diagnosis of haemochromatosis. A study of 43 families.

  1977cited by this paper
• Hereditary hemochromatosis. Diagnosis in siblings and children.

  1977cited by this paper
• Long term results of venesection therapy in idiopathic haemochromatosis.

  1976cited by this paper
• Measurement of serum ferritin by a 2-site immunoradiometric assay.

  1974cited by this paper
• Iron storage disorders of the liver.

  1974cited by this paper
• An immunoradiometric assay for ferritin in the serum of normal subjects and patients with iron deficiency and iron overload

  1972cited by this paper
• Hepatoma developing in hemochromatosis in spite of adequate treatment by multiple phlebotomies

  1971cited by this paper

• Health Economic Evaluations of Hemochromatosis Screening and Treatment: A Systematic Review

  2024influential citation
• Burden of iron overload among non-chronically blood transfused preschool children with sickle cell anaemia

  2021cites this paper
• Serum Iron Markers in Relation to Hepatocellular Carcinoma Risk Among Patients with Non-Alcoholic Fatty Liver Disease by

  2021cites this paper
• Serum Biomarkers of Iron Status and Risk of Hepatocellular Carcinoma Development in Patients with Nonalcoholic Fatty Liver Disease

  2021cites this paper
• A Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis

  2015cites this paper
• Serum or plasma ferritin concentration as an index of iron deficiency and overload.

  2015cites this paper
• A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy

  2013cites this paper
• Iron Metabolism and Related Disorders

  2013cites this paper
• The adaptability of red blood cells

  2013cites this paper
• Porfiria cutânea tardia com mutações do gene da hemocromatose C282Y e H63D e análise retrospectiva do perfil de ferro em relação ao tratamento: estudo de 60 casos

  2012cites this paper
• Systematische Untersuchung zur Prävalenz der Hämochromatose bei Patienten mit primär nicht insulinpflichtigem Diabetes mellitus

  2011cites this paper
• Arvelig hemokromatose - nytten av screening

  2009cites this paper
• Metabolic disorders and storage diseases

  2008cites this paper
• Hemochromatosis gene (HFE) mutations in patients with type 2 diabetes and their control group in an Iranian population.

  2008cites this paper
• Quels marqueurs pour le bilan martial

  2007cites this paper
• Serum ferritin in colorectal cancer patients and its prognostic evaluation.

  2006cites this paper
• Screening for Hereditary Hemochromatosis: A Systematic Review for the U.S. Preventive Services Task Force

  2006cites this paper
• Serum Ferritin in Colorectal Cancer Patients and its Prognostic Evaluation

  2006cites this paper
• Screening for HFE and Iron Overload

  2005cites this paper
• Screening Primary Care Patients for Hereditary Hemochromatosis with Transferrin Saturation and Serum Ferritin Level: Systematic Review for the American College of Physicians

  2005cites this paper
• Initial Screening Transferrin Saturation Values, Serum Ferritin Concentrations, and HFE Genotypes in Whites and Blacks in the Hemochromatosis and Iron Overload Screening Study

  2005cites this paper
• Genotype-based screening for hereditary haemochromatosis. I: Technical performance, costs and clinical relevance of a German pilot study

  2005cites this paper
• Association of porphyria cutanea tarda with hereditary hemochromatosis.

  2004cites this paper
• Prevalence of C282Y and E168X HFE mutations in an Italian population of Northern European ancestry.

  2003cites this paper
• Prevalence of HFE mutations in upper Northern Italy: study of 1132 unrelated blood donors.

  2003cites this paper
• Screening for Iron Overload in the Turkish Population

  2003cites this paper
• Screening for hemochromatosis.

  2002cites this paper
• Prevalence of coronary heart disease associated with HFE mutations in adults attending a health appraisal center.

  2002cites this paper
• Should we screen for hemochromatosis? An examination of evidence of downstream effects on morbidity and mortality.

  2002cites this paper
• Normal Increased serum iron concentration Increased hepatic iron concentration Tissue injury Cirrhosis , organ failure

  2002cites this paper
• Benefit of Population-based Screening for Phenotypic Hemochromatosis in Young Men

  2002cites this paper
• Strategies for early diagnosis of haemochromatosis

  2002cites this paper
• Is an elevated serum transferrin saturation associated with the development of diabetes?

  2002cites this paper
• Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels.

  2002cites this paper
• Screening for Hemochromatosis in Turkey

  2002cites this paper
• Recognition and management of hereditary hemochromatosis.

  2002cites this paper
• Prevalence of hemochromatosis-related symptoms among individuals with mutations in the HFE gene.

  2002cites this paper
• Hemochromatosis Detection in a Health Screening Program at an Alabama Forest Products Mill

  2002cites this paper
• Prevention in Liver Disease

  2001cites this paper
• Genetic Hemochromatosis, a Celtic Disease: Is It Now Time for Population Screening?

  2001cites this paper
• HFE Gene and HUMAN GENOME EPIDEMIOLOGY (HuGE) REVIEWS HFE Gene and Hereditary Hemochromatosis: A HuGE Review

  2001cites this paper
• HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology.

  2001cites this paper
• A simple, highly sensitive and improved method for the measurement of bleomycin-detectable iron: the 'catalytic iron index' and its value in the assessment of iron status in haemochromatosis.

  2001cites this paper
• Diagnosis and management of hemochromatosis

  2001cites this paper
• Hereditary Hemochromatosis: A Disease for All Physicians

  2001cites this paper
• Hemochromatosis as a Risk Factor for Fulminant staphylococcus aureus Pneumonia

  2001cites this paper
• Screening for Hemochromatosis: High Prevalence and Low Morbidity in an Unselected Population of 65,238 Persons

  2001cites this paper
• Screening for Hemochromatosis in Routine Medical Care: An Evaluation of Mean Corpuscular Volume and Mean Corpuscular Hemoglobin

  2000cites this paper
• Wellness assessment: A role for laboratory medicine.

  2000cites this paper
• Cost-Effectiveness of Population-Based Genetic Hemochromatosis Screening

  2000cites this paper
• Stoffwechselerkrankungen der Leber

  2000cites this paper
• Contribution of different HFE genotypes to iron overload disease: a pooled analysis

  2000cites this paper
• [Hemochromatosis].

  2000cites this paper
• [Hyperferritinemia].

  2000cites this paper
• Trace Element Requirements in the Elderly

  2000cites this paper
• Labile Blood Components and Blood Donation

  2000cites this paper
• A Pilot C282Y Hemochromatosis Screening in Italian Newborns by TaqMan™ Technology

  2000cites this paper
• Analysis of HFE-codon 63/282 (H63D/C282Y) gene variants in mexican mestizos. Blood donors and patients with hereditary hemochromatosis.

  2000cites this paper
• Total iron-binding capacity and serum transferrin determination under the influence of several clinical conditions.

  2000cites this paper
• Prevalence of HFE (hemochromatosis gene) mutations in unselected male patients with type 2 diabetes.

  2000cites this paper
• Screening for hereditary hemochromatosis: are DNA-based tests the answer?

  1999cites this paper
• Hereditary hemochromatosis: impact of molecular and iron-based testing on the diagnosis, treatment, and prevention of a common, chronic disease.

  1999cites this paper
• Evaluation of a workplace hemochromatosis screening program.

  1999cites this paper
• Update on hereditary hemochromatosis and the HFE gene.

  1999cites this paper
• [Endocrine complications of genetic hemochromatosis].

  1999cites this paper
• Screening for Hemochromatosis: Phenotyping or Genotyping or Both?

  1999cites this paper
• Using outcomes data to identify best medical practice: the role of policy models.

  1999cites this paper
• Current Clinical Practice: Hereditary Haemochromatosis: Recent Advances in Biology and Management.

  1999cites this paper
• [Hereditary hemochromatosis--new developments after discovery of the HFE gene].

  1999cites this paper
• Hereditary haemochromatosis: diagnosis and management in the gene era.

  1999cites this paper
• Les complications endocriniennes de l'hémochromatose génétique

  1999cites this paper
• Molecular medicine and hemochromatosis: at the crossroads.

  1999cites this paper
• Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects.

  1998cites this paper
• Screening for Hemochromatosis and Iron Deficiency in Employees and Primary Care Patients in Western Germany

  1998cites this paper
• Prevalence of Elevated Serum Transferrin Saturation in Adults in the United States

  1998cites this paper
• Hemochromatosis: genetics helps to define a multifactorial disease

  1998cites this paper
• The significance of haemochromatosis gene mutations in the general population: implications for screening

  1998cites this paper
• Hemochromatosis: new insights in pathogenesis and diagnosis following the discovery of the gene.

  1998cites this paper
• Prevalence of Hereditary Hemochromatosis in 16 031 Primary Care Patients

  1998cites this paper
• Screening for Hemochromatosis in Primary Care Settings

  1998cites this paper
• Hereditary hemochromatosis: gene discovery and its implications for population-based screening.

  1998cites this paper
• Iron Overload, Public Health, and Genetics: Evaluating the Evidence for Hemochromatosis Screening

  1998cites this paper
• The significance of haemochromatosis gene mutations in the general population: implications for screening.

  1998cites this paper
• Hereditary hemochromatosis.

  1998cites this paper
• Screening for hemochromatosis: phenotype versus genotype.

  1998cites this paper
• Taking a count: the evaluation of genetic testing

  1998cites this paper
• Prevalence of hereditary hemochromatosis in a Massachusetts corporation: Is Celtic origin a risk factor?

  1997cites this paper
• the screening, diagnosis and optimal management of haemochromatosis

  1997cites this paper
• Clinical aspects of diabetes secondary to idiopathic haemochromatosis in French-speaking Belgium.

  1997cites this paper
• A laboratorian's perspective on evaluation and implementation of new laboratory tests.

  1997cites this paper
• Leberzirrhosen als Präkanzerosen

  1997cites this paper
• Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers.

  1997cites this paper
• [Should we screen for hemochromatosis? Critical analysis of the literature].

  1997cites this paper
• [Liver cirrhosis as precancerous conditions].

  1997cites this paper
• Haemochromatosis presenting with loss of libido and impotence.

  1996cites this paper
• Genetic hemochromatosis: pathogenesis, diagnosis, and therapy.

  1996cites this paper
• Haemochromatosis Associated with Arthritis and Hypopituitarism

  1996cites this paper
• Pediatric gastroenterology. Update on metabolic liver disease.

  1996cites this paper
• A reader's guide to economic analysis in the GI literature.

  1996cites this paper
• Iron in an Australian population: Too little or too much?

  1996cites this paper